Instruction for use: Celiprol

Active substance Celiprolol

ATX Code C07AB08 Celiprolol

Pharmacotherapeutic group:

Beta-blockers

The nosological classification (ICD-10)

I10 Essential (primary) hypertension

Hypertension, Arterial hypertension, Arterial hypertension crisis course, Essential Hypertension

Primary hypertension, Arterial hypertension, complications of diabetes, hypertension, The sudden increase in blood pressure, Hypertensive disorders of blood circulation, hypertensive condition, hypertensive crises, hypertension, arterial Hypertension, malignant Hypertension, Hypertonic disease, Hypertensive crisis, Hypertension, accelerated hypertension, malignant hypertension, The aggravation of hypertensive disease, Transient hypertension, Isolated systolic hypertension

I15 Secondary hypertension

Arterial hypertension, complications of diabetes, hypertension, The sudden rise in blood pressure, Hypertensive disorders of blood circulation, hypertensive condition, hypertensive crises, hypertension, arterial hypertension, malignant hypertension, Hypertensive crisis, Hypertension, accelerated hypertension, malignant hypertension, hypertensive crisis, The aggravation of hypertensive disease, Transient hypertension, hypertension, Arterial hypertension, Arterial hypertension crisis course, renovascular hypertension, symptomatic hypertension, renal hypertension, Renovascular hypertension, Symptomatic hypertension

I20 Angina [cardiac angina]

heberden disease, Angina pectoris, The attack of angina pectoris, recurrent angina, Spontaneous angina, Stable angina pectoris, angina, Angina (attack), Angina rest, Angina progressing, Angina mixed, Angina spontaneous, stable angina, Chronic stable angina, Angina Syndrome X

I20-I25 Ischaemic heart disease

Structure and Composition

1 tablet coated liner contains tseliprola hydrochloride 100 mg or 200 mg; in blisters of 15 or 10 pc., in a cardboard unit 2 or 3 packaging or in bottles of 100 pcs., in a cardboard unit 1 vial.

pharmachologic effect

antianginal, hypotensive.

Indications

Arterial hypertension, coronary heart disease (prevention and treatment of angina attacks).

Contraindications

Hypersensitivity, AV block II and III degree sinoatrial block, sick sinus syndrome, bradycardia, acute or chronic (heavy flow) heart failure, cardiogenic shock, hypotension, untreated phaeochromocytoma, metabolic acidosis, asthma, obliterative lower limb disease, children .

Pregnancy and breast-feeding

Perhaps if the expected effect of therapy outweighs the potential risk to the fetus or child.

Side effects

From the nervous system and sensory organs: increased fatigue, headache, dizziness, sleep disorders, depression, tremors.

Cardio-vascular system and blood (blood, hemostasis): AV-block, hypotension, heart failure. From the digestive tract: nausea, diarrhea or constipation.

Allergic reactions: skin rash, itching, worsening of psoriasis, psoriazoformnye exanthema.

Other: muscle weakness, chills, feeling cold snap in extremities, decrease the formation of tear fluid, bronchospasm, reduced potency, hypoglycemia.

Dosing and Administration

Inside, on an empty stomach or 2 hours after a meal with a liquid, - 200 mg / day in a single step, gradually increasing the dose to 400 mg. The maximum daily dose - 600 mg. If abnormal liver and kidney function - 100mg once.

Precautionary measures

Be wary appoint patients with diabetes, hyperthyroidism, myasthenia gravis, depression, with impaired liver and kidney function, allergic history, patients who use contact lenses. In patients with pheochromocytoma treatment is possible only against the background of alpha-blockers. Cancelling should gradually within 1-2 weeks. Be wary of during the drivers of vehicles and people skills relate to the high concentration of attention.

Storage conditions

In a dry place at a temperature of 10-25 ° C.

Keep out of the reach of children.